IronOak Wealth LLC. Acquires Shares of 3,056 Intuitive Surgical, Inc. (NASDAQ:ISRG)

IronOak Wealth LLC. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 3,056 shares of the medical equipment provider's stock, valued at approximately $1,595,000. Intuitive Surgical comprises 1.8% of IronOak Wealth LLC.'s portfolio, making the stock its 21st largest holding.

Several other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new position in Intuitive Surgical in the fourth quarter valued at about $2,401,493,000. Proficio Capital Partners LLC lifted its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after buying an additional 948,902 shares during the period. Capital Research Global Investors lifted its stake in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares during the period. Raymond James Financial Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at about $313,769,000. Finally, Northern Trust Corp lifted its stake in Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares during the period. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Robert W. Baird cut their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Finally, Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $596.05.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 492 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the sale, the senior vice president now directly owns 4,056 shares in the company, valued at $2,327,251.68. The trade was a 10.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,111 shares of company stock worth $15,364,055 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

ISRG stock traded down $4.61 during mid-day trading on Friday, reaching $551.14. The company had a trading volume of 2,091,011 shares, compared to its average volume of 1,647,905. The stock has a 50 day simple moving average of $516.44 and a two-hundred day simple moving average of $538.53. The company has a market capitalization of $197.54 billion, a price-to-earnings ratio of 85.98, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52 week low of $396.48 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the company posted $1.50 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.